{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:49:44Z","timestamp":1791308984080,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013256","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000}}],"reference-count":180,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013256.pub2","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T09:44:36Z","timestamp":1603532676000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease"],"prefix":"10.1002","volume":"2021","author":[{"given":"Cindy CY","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Medicine; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Medicine; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Medicine; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Biology; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Western Ontario; London Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Narula","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.14309\/00000434-201310001-01856","article-title":"Preoperative methotrexate and risk for early postoperative complications in inflammatory bowel disease: A single-center academic experience","volume":"108","author":"Afzali","year":"2013","journal-title":"The American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/MIB.0000000000000780","article-title":"Preoperative use of methotrexate and the risk of early postoperative complications in patients with inflammatory bowel disease","volume":"22","author":"Afzali","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10350-006-0782-0","article-title":"Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients","volume":"50","author":"Alves","year":"2007","journal-title":"Diseases of the Colon & Rectum"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","article-title":"Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients","volume":"12","author":"Appau","year":"2008","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00595-013-0809-9","article-title":"Risk factors for surgical site infection in Japanese patients with ulcerative colitis: A multicenter prospective study","volume":"44","author":"Araki","year":"2014","journal-title":"Surgery Today"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0007|cit7","first-page":"e38","article-title":"Evaluating the impact of vedolizumab on postoperative complications in inflammatory bowel disease patients","volume":"61","author":"Ayoub","year":"2018","journal-title":"Diseases of the Colon and Rectum"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.crohns.2011.08.014","article-title":"Infliximab and complications after colectomy in patients with ulcerative colitis","volume":"6","author":"Bregnbak","year":"2012","journal-title":"Journal of Crohn's & colitis"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/SLA.0000000000002017","article-title":"Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: Results of a prospective nationwide cohort","volume":"267","author":"Brouquet","year":"2018","journal-title":"Annals of Surgery"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1463-1318.2010.02469.x","article-title":"Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?","volume":"13","author":"Canedo","year":"2011","journal-title":"Colorectal Disease"},{"issue":"6 Supplement 1","key":"10.1002\/14651858.CD013256.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S0016-5085(19)36987-2","article-title":"Anti-tumor necrosis factor therapy is not associated with post-operative infection: results from prospective cohort of ulcerative colitis and Crohn's disease patients undergoing surgery to identify risk factors for post-operative infection I (PUCCINI)","volume":"156","author":"Cohen","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s00464-009-0861-0","article-title":"Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: A case-matched study","volume":"24","author":"Coquet-Reinier","year":"2010","journal-title":"Surgical Endoscopy and Other Interventional Techniques"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/bjs.10595","article-title":"Short and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres","volume":"104","author":"De Buck Van Overstraeten","year":"2017","journal-title":"British Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/00365521.2012.660540","article-title":"Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease","volume":"47","author":"El-Hussuna","year":"2012","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.crohns.2012.03.013","article-title":"Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis","volume":"7","author":"Eshuis","year":"2013","journal-title":"Journal of Crohn's & colitis"},{"issue":"7","key":"10.1002\/14651858.CD013256.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ibd.20863","article-title":"Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis","volume":"15","author":"Ferrante","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ecco-jcc\/jjx095","article-title":"Perioperative use of Vedolizumab is not associated with postoperative infectious complications in patients with Ulcerative Colitis undergoing colectomy","volume":"11","author":"Ferrante","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S581","DOI":"10.1016\/S0016-5085(17)32096-6","article-title":"Perioperative use of vedolizumab is not associated with postoperative infectious complications in patients with ulcerative colitis undergoing (procto) colectomy with ileal pouch-anal anastomosis","volume":"152","author":"Ferrante","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ajg.2016.541","article-title":"Postoperative complications after ileocecal resection in Crohn's disease: A prospective study from the REMIND group","volume":"112","author":"Fumery","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0021|cit21","first-page":"S239","article-title":"Postoperative complications after ileo-caecal resection in Crohn\u2019s Disease: a prospective multicentre study","volume":"9","author":"Fumery","year":"2015","journal-title":"Journal of Crohn's and Colitis"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11605-010-1385-6","article-title":"Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis","volume":"15","author":"Gainsbury","year":"2011","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DCR.0b013e3182a0e702","article-title":"Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-alpha therapy","volume":"56","author":"Gu","year":"2013","journal-title":"Diseases of the Colon & Rectum"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0024|cit24","first-page":"S350","article-title":"Prevalence and risk factors for postoperative septic complications in Crohn's disease","volume":"10","author":"Guasch","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1053\/j.gastro.2017.11.180","article-title":"An analysis of surgical outcomes in IBD patients treated with and without biologic therapy","volume":"154","author":"Gudsoorkar","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00384-017-2751-6","article-title":"Risk factors of surgical site infections in patients with Crohn's disease complicated with gastrointestinal fistula","volume":"32","author":"Guo","year":"2017","journal-title":"International Journal of Colorectal Disease"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ibd\/izx036","article-title":"Postoperative morbidity risks following ileocolic resection for Crohn's disease treated with anti-TNF alpha therapy: A retrospective study of 360 patients","volume":"24","author":"Jouvin","year":"2018","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S1294","DOI":"10.1016\/S0016-5085(18)34241-0","article-title":"Risk of post-operative complications among Crohn's disease patients treated pre-operatively with vedolizumab. A matched case-control study","volume":"154","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10620-016-4400-2","article-title":"Tumor necrosis factor alpha inhibitors did not influence postoperative morbidity after elective surgical resections in Crohn's disease","volume":"62","author":"Kotze","year":"2017","journal-title":"Digestive Diseases & Sciences"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/DCR.0b013e3182759029","article-title":"Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease","volume":"56","author":"Krane","year":"2013","journal-title":"Diseases of the Colon & Rectum"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications","volume":"12","author":"Kunitake","year":"2008","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jgh3.12072","article-title":"Risk factors for post-operative infection after gastrointestinal surgery among adult patients with inflammatory bowel disease: Findings from a large observational US cohort study","volume":"2","author":"Liang","year":"2018","journal-title":"JGH Open"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/apt.14459","article-title":"Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations","volume":"47","author":"Lightner","year":"2018","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6 Supplement 1","key":"10.1002\/14651858.CD013256.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S1294","DOI":"10.1016\/S0016-5085(18)34242-2","article-title":"Intra-abdominal sepsis following ileocolic resection for Crohn's disease: what are the risk factors and are they consistent internationally?","volume":"154","author":"Lightner","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00054725-200209000-00001","article-title":"Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications","volume":"8","author":"Mahadevan","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"issue":"7","key":"10.1002\/14651858.CD013256.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study","volume":"19","author":"Marchal","year":"2004","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/DCR.0000000000001153","article-title":"Intra-Abdominal sepsis after ileocolic resection in Crohn's Disease: The role of combination immunosuppression","volume":"61","author":"McKenna","year":"2018","journal-title":"Diseases of the Colon and Rectum"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy","volume":"51","author":"Mor","year":"2008","journal-title":"Diseases of the Colon & Rectum"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ecco-jcc\/jjv051","article-title":"Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn's disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome","volume":"9","author":"Morar","year":"2015","journal-title":"Journal of Crohn's & colitis"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/DCR.0b013e3181a7ba96","article-title":"Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for crohn's disease","volume":"52","author":"Myrelid","year":"2009","journal-title":"Diseases of the Colon and Rectum"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.9439","article-title":"Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy","volume":"101","author":"Myrelid","year":"2014","journal-title":"British Journal of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s11605-010-1341-5","article-title":"Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease","volume":"14","author":"Nasir","year":"2010","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.crohns.2014.07.007","article-title":"The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease","volume":"8","author":"Nguyen","year":"2014","journal-title":"Journal of Crohn's & colitis"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1365-2036.2012.05099.x","article-title":"Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study","volume":"35","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/apt.12159","article-title":"Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study","volume":"37","year":"2013","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jjz129","article-title":"Case-matched comparison of postoperative outcomes following surgery for inflammatory bowel disease after exposure to vedolizumab vs other biologics","volume":"14","author":"Novello","year":"2020","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1463-1318.2010.02186.x","article-title":"Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal","volume":"13","author":"Regadas","year":"2011","journal-title":"Colorectal Disease"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00384-011-1236-2","article-title":"Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience","volume":"26","author":"Rizzo","year":"2011","journal-title":"International Journal of Colorectal Disease"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1093\/ecco-jcc\/jjx002.570","article-title":"Perioperative use of vedolizumab seems not associated with short-term postoperative infectious complications in patients with Crohn's disease undergoing right hemicolectomy with ileocolonic anastomosis","volume":"11","author":"Schils","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10350-007-9008-3","article-title":"Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?","volume":"50","author":"Schluender","year":"2007","journal-title":"Diseases of the Colon and Rectum"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jamcollsurg.2006.12.044","article-title":"Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis","volume":"204","author":"Selvasekar","year":"2007","journal-title":"Journal of the American College of Surgeons"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/bjs.9152","article-title":"The effect of immune therapy on surgical site infection following Crohn's Disease resection","volume":"100","author":"Serradori","year":"2013","journal-title":"British Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1016\/S0016-5085(17)31469-5","article-title":"Surgical outcomes among inflammatory bowel disease patients undergoing colectomy: Results from a national database","volume":"152","author":"Shaib","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S1261","DOI":"10.1016\/S0016-5085(16)34263-9","article-title":"Do anti-TNF agents affect postoperative outcomes in patients undergoing surgery for inflammatory bowel disease?","volume":"150","author":"Divino","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013256.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s11605-016-3194-z","article-title":"Effect of anti-TNF agents on postoperative outcomes in inflammatory bowel disease patients: a single institution experience","volume":"20","author":"Shwaartz","year":"2016","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ajg.2012.464","article-title":"Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients","volume":"108","author":"Syed","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/DCR.0b013e318247c433","article-title":"Influence of risk factors on the safety of ileocolic anastomosis in crohn's disease surgery","volume":"55","author":"Tzivanakis","year":"2012","journal-title":"Diseases of the Colon and Rectum"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/DCR.0b013e3181bb0d1d","article-title":"Risk factors associated with surgical site infection after ileal pouch-anal anastomosis in ulcerative colitis","volume":"53","author":"Uchino","year":"2010","journal-title":"Diseases of the Colon & Rectum"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/DCR.0b013e31829f682c","article-title":"Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease","volume":"56","author":"Uchino","year":"2013","journal-title":"Diseases of the Colon & Rectum"},{"issue":"9","key":"10.1002\/14651858.CD013256.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00384-013-1700-2","article-title":"Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis","volume":"28","author":"Uchino","year":"2013","journal-title":"International Journal of Colorectal Disease"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000437362","article-title":"Does pre-operative multiple immunosuppressive therapy associate with surgical site infection in surgery for ulcerative colitis","volume":"92","author":"Uchino","year":"2015","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00384-019-03253-x","article-title":"Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics","volume":"34","author":"Uchino","year":"2019","journal-title":"International Journal of Colorectal Disease"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/codi.13937","article-title":"Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study","volume":"20","author":"Ward","year":"2018","journal-title":"Colorectal Disease"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2011-301495","article-title":"Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease","volume":"62","author":"Waterman","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjsurg.2014.04.010","article-title":"Organ space infection following ileocolectomy for Crohn's disease: a national surgical quality improvement project study","volume":"208","author":"Wilson","year":"2014","journal-title":"American Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"S574","DOI":"10.1016\/S0016-5085(17)32078-4","article-title":"Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with anti-integrin and anti-tumor necrosis factor agents","volume":"152","author":"Yamada","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013256.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/ajg.2017.201","article-title":"Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with vedolizumab","volume":"112","author":"Yamada","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/BF02236563","article-title":"Risk factors for intra-abdominal sepsis after surgery in Crohn's disease","volume":"43","author":"Yamamoto","year":"2000","journal-title":"Diseases of the Colon & Rectum"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9610(99)00165-8","article-title":"Factors affecting the incidence of postoperative septic complications and recurrence after strictureplasty for jejunoileal Crohn's disease","volume":"178","author":"Yamamoto","year":"1999","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1873-9946(14)60123-9","article-title":"The risk of postoperative complications following preoperative immunosuppressive therapy in patients undergoing ileocolonic resection for Crohn's disease","volume":"8","author":"Yamamoto","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/2050640615600116","article-title":"Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study","volume":"4","author":"Yamamoto","year":"2016","journal-title":"United European Gastroenterology Journal"},{"issue":"9","key":"10.1002\/14651858.CD013256.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/ibd\/izz010","article-title":"The influence of preoperative medications on postoperative complications in patients after intestinal surgery for Crohn's disease","volume":"25","author":"Yu","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/MIB.0000000000000919","article-title":"Preoperative anti-tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications after ileal pouch-anal anastomosis","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF02058701","article-title":"Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis","volume":"39","author":"Ziv","year":"1996","journal-title":"Diseases of the Colon & Rectum"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0075|cit75","first-page":"454","article-title":"Risk factors for postoperative intra-abdominal septic complications in Crohn's disease","volume":"19","author":"Zuo","year":"2014","journal-title":"Chinese Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/SLA.0000000000002275","article-title":"Higher surgical morbidity for ulcerative colitis patients in the era of biologics","volume":"268","author":"Abelson","year":"2018","journal-title":"Annals of Surgery"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0077|cit77","first-page":"S133","article-title":"Impact of immunosuppressants on postoperative complications following colectomies for Crohn's disease: results from the ACS-NSQIP database","volume":"59","author":"Abou Khalil","year":"2016","journal-title":"Canadian Journal of Surgery"},{"issue":"S2","key":"10.1002\/14651858.CD013256.pub2-BIB0078|cit78","first-page":"48","article-title":"The influence of steroid therapy (ST) on the postoperative frequency of development and peculiarities of the wound infection behavior in patients with ulcerative colitis (UC)","volume":"17","author":"Achkasov","year":"2015","journal-title":"Colorectal Disease"},{"issue":"S4","key":"10.1002\/14651858.CD013256.pub2-BIB0079|cit79","first-page":"46","article-title":"Are there patient or operative factors associated with septic complications following ileocolonic resection for Crohn\u2019s disease? - single centre contemporaneous cohort","volume":"20","author":"Adegbola","year":"2018","journal-title":"Colorectal Disease"},{"issue":"S7","key":"10.1002\/14651858.CD013256.pub2-BIB0080|cit80","first-page":"47","article-title":"Ileocolonic resection for Crohn's disease - perioperative outcomes in a contemporary cohort from a single tertiary centre","volume":"20","author":"Adegbola","year":"2018","journal-title":"Colorectal Disease"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.14309\/00000434-201610001-00647","article-title":"The influence of vedolizumab on postoperative outcomes in IBD patients undergoing abdominal surgery","volume":"111","author":"Aelvoet","year":"2016","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jss.2017.05.077","article-title":"Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis","volume":"219","author":"Andrew","year":"2017","journal-title":"Journal of Surgical Research"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MCG.0b013e3182677003","article-title":"Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease","volume":"47","author":"Bafford","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000381033","article-title":"Safety of proctocolectomy for ulcerative colitis under elective and non-elective circumstances: preoperative corticosteroid treatment worsens outcome","volume":"32","author":"Balachandran","year":"2015","journal-title":"Digestive Surgery"},{"issue":"S4","key":"10.1002\/14651858.CD013256.pub2-BIB0085|cit85","first-page":"47","article-title":"Effect of anti TNF\u03b1 on postoperative outcomes after ileocolic resection for Crohn disease","volume":"20","author":"Benichou","year":"2018","journal-title":"Colorectal Disease"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1016\/S0016-5085(13)60665-4","article-title":"Immunosuppressant therapy prior to elective surgery is not associated with increased post-operative morbidity in ulcerative colitis","volume":"144","author":"Bewtra","year":"2013","journal-title":"Gastroenterology"},{"issue":"8S","key":"10.1002\/14651858.CD013256.pub2-BIB0087|cit87","first-page":"A652","article-title":"The preoperative use of anti-TNF \u03b1-antibodies in IBD patients undergoing resective abdominal surgery has no influence on peri- and postoperative complications","volume":"6","author":"Braun","year":"2018","journal-title":"United European Gastroenterology Journal"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00268-003-6972-1","article-title":"Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohn's disease","volume":"27","author":"Bruewer","year":"2003","journal-title":"World Journal of Surgery"},{"issue":"8S","key":"10.1002\/14651858.CD013256.pub2-BIB0089|cit89","first-page":"A254","article-title":"Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease in the biological era in Spain: results of the nationwide EpidemIBD study of Geteccu","volume":"6","author":"Chaparro","year":"2018","journal-title":"United European Gastroenterology Journal"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S773","DOI":"10.14309\/00000434-201510001-01817","article-title":"Vedolizumab therapy in Crohn's disease and ulcerative colitis: a retrospective review of post-procedural complications","volume":"110","author":"Chiplunker","year":"2015","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/S1873-9946(12)60410-3","article-title":"Risk of short-term postoperative complications in patients treated with azathioprine for Crohn's disease. A single center experience","volume":"6","author":"Coscia","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"S2","key":"10.1002\/14651858.CD013256.pub2-BIB0092|cit92","first-page":"6","article-title":"Short-term postoperative complications in patients treated with azathioprine for Crohn's disease","volume":"14","author":"Vitali","year":"2012","journal-title":"Colorectal Disease"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S1063","DOI":"10.1016\/S0016-5085(12)64124-9","article-title":"Timing of pre-operative anti-tumor necrosis factor therapy does not affect early post-operative complication rates in inflammatory bowel disease patients undergoing intestinal resection","volume":"142","author":"Desai","year":"2012","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2011.07.016","article-title":"Postoperative complications and mortality following colectomy for ulcerative colitis","volume":"9","author":"De Silva","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0095|cit95","first-page":"S431","article-title":"Postoperative complications after intestinal resection in Crohn's disease: analysis from the Practicrohn study","volume":"10","author":"Domenech","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0033-1356347","article-title":"Impact of perioperative immunosuppressive medication on surgical outcome in Crohn's disease (CD)","volume":"52","author":"Eisner","year":"2014","journal-title":"Zeitschrift fur Gastroenterologie"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0097|cit97","first-page":"101","article-title":"Postoperative complications in Crohn's disease. Are they related to recurrence promoting factors? A preliminary study","volume":"12","author":"Fronda","year":"1999","journal-title":"Chirurgia"},{"issue":"33","key":"10.1002\/14651858.CD013256.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.3748\/wjg.v20.i33.11808","article-title":"Impact of medical therapy on patients with Crohn's disease requiring surgical resection","volume":"20","author":"Fu","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1093\/ecco-jcc\/jjx180.347","article-title":"Safety of stricturoplasty for Crohn\u2019s disease in the era of biologics","volume":"12","author":"Gamaleldin","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.23209","article-title":"Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care & Research"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1016\/S0016-5085(14)62119-3","article-title":"Clinical risk factors for complications after laparoscopic ileal-pouch-anal anastomosis in patients with ulcerative colitis","volume":"146","author":"Gonzalez","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0102|cit102","first-page":"A77","article-title":"Rates of wound healing in patients with Crohn's disease undergoing proctectomy","volume":"68","author":"Grant","year":"2019","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1093\/ecco-jcc\/jjy222.333","article-title":"Rates of wound healing in patients with Crohn's disease undergoing proctectomy","volume":"13 Supplement 1","author":"Grant","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ecco-jcc\/jjy148","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease do not impact serious infections after arthroplasty","volume":"13","author":"Gregory","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6 Supplement 1","key":"10.1002\/14651858.CD013256.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1016\/S0016-5085(18)31629-9","article-title":"Outcomes after joint replacement surgery in patients with inflammatory bowel disease","volume":"154","author":"Gregory","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00000658-198504000-00015","article-title":"Early complications following surgical treatment for Crohn's disease","volume":"201","author":"Heimann","year":"1985","journal-title":"Annals of Surgery"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/BF02234594","article-title":"Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications","volume":"44","author":"Hyde","year":"2001","journal-title":"Diseases of the Colon and Rectum"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SLA.0000000000002628","article-title":"Postoperative mortality after nonelective surgery for inflammatory bowel disease patients in the era of biologics","volume":"269","author":"Justiniano","year":"2019","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/000313481808400962","article-title":"Effects of preoperative use of biologic agents on operative outcomes in Crohn's disease patients","volume":"84","author":"Kamel","year":"2018","journal-title":"The American Surgeon"},{"issue":"7","key":"10.1002\/14651858.CD013256.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ibd.21860","article-title":"Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery","volume":"18","author":"Kasparek","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0111|cit111","first-page":"469","article-title":"Risk factors for complications after abdominal surgery in Crohn's disease","volume":"62","author":"Kimura","year":"2019","journal-title":"Diseases of the Colon & Rectum"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/DCR.0000000000001574","article-title":"Clinical and genetic factors associated with complications after Crohn's ileocolectomy","volume":"63","author":"Kline","year":"2020","journal-title":"Diseases of the Colon & Rectum"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00054725-201112002-00133","article-title":"Biological therapy does not increase post operative complications after major abdominal surgery in Crohn's disease Brazilian patients","volume":"17","author":"Kotze","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/codi.13929","article-title":"Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case-matched study","volume":"20","author":"Kotze","year":"2017","journal-title":"Colorectal Disease"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"S358","DOI":"10.1016\/S0016-5085(18)31516-6","article-title":"Vedolizumab and early postoperative complications in non-intestinal surgery: a case-matched analysis","volume":"154","author":"Almutairdi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756284818783614","article-title":"Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis","volume":"11","author":"Kotze","year":"2018","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"S2","key":"10.1002\/14651858.CD013256.pub2-BIB0117|cit117","first-page":"A227","article-title":"Preoperative ciclosporin therapy and appropriate steroid use does not increase risk of infective complications following colectomy for ulcerative colitis","volume":"61","author":"Krupa","year":"2012","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD013256.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"e171538","DOI":"10.1001\/jamasurg.2017.1538","article-title":"Association of preoperative anti-tumor necrosis factor therapy with adverse postoperative outcomes in patients undergoing abdominal surgery for ulcerative colitis","volume":"152","author":"Kulaylat","year":"2017","journal-title":"JAMA Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1093\/ecco-jcc\/jjx180.507","article-title":"Risk factors for poor postoperative outcome in patients with Crohn\u2019s disease undergoing ileocaecal resection","volume":"12","author":"Labidi","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1016\/S0016-5085(13)61500-0","article-title":"Influence of biologic agents on short-term postoperative complications in patients with Crohn's disease: a prospective, single-surgeon cohort study","volume":"144","author":"Lau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/0366-6999.176072","article-title":"Preoperative corticosteroid usage and hypoalbuminemia increase occurrence of short\u2011term postoperative complications in Chinese patients with ulcerative colitis","volume":"129","author":"Li","year":"2016","journal-title":"Chinese Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jjw147","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/MIB.0000000000001248","article-title":"Surgical outcomes in vedolizumab-treated patients with ulcerative colitis","volume":"23","author":"Lightner","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ecco-jcc\/jjx163","article-title":"Postoperatve outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn's disease","volume":"12","author":"Lightner","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/ecco-jcc\/jjx002.482","article-title":"A multi-institutional report of postoperative outcomes in vedolizumab-treated patients undergoing major abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ibd\/izx076","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing major abdominal operations for inflammatory bowel disease: retrospective multicenter cohort study","volume":"24","author":"Lightner","year":"2018","journal-title":"Inflammatory Bowel Diseases"},{"issue":"S2","key":"10.1002\/14651858.CD013256.pub2-BIB0127|cit127","first-page":"101","article-title":"Have changes in medical therapy and surgical techniques for the treatment of ulcerative colitis altered post-colectomy outcomes over the past 26 years?","volume":"33","author":"Lim","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcol.2018.04.001","article-title":"Risk factors for postoperative complications in Crohn disease: analysis of 173 patients","volume":"38","author":"Melo-Pinto","year":"2018","journal-title":"Journal of Coloproctology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00384-017-2850-4","article-title":"Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease","volume":"32","author":"Monsinjon","year":"2017","journal-title":"International Journal of Colorectal Disease"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"S1218","DOI":"10.1016\/S0016-5085(16)34123-3","article-title":"Does tacrolimus affect the outcome after surgery for ulcerative colitis?","volume":"150","author":"Nagao","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00384-018-3212-6","article-title":"Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis","volume":"34","author":"Novello","year":"2019","journal-title":"International Journal of Colorectal Disease"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0132|cit132","first-page":"S196","article-title":"The risk of preoperative anti-TNF-alpha treatment on early postoperative complications in patients with Crohn's disease","volume":"8","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apt.14842","article-title":"Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease","volume":"48","author":"Park","year":"2018","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6 Supplement 1","key":"10.1002\/14651858.CD013256.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1016\/S0016-5085(18)31534-8","article-title":"Risk of postoperative surgical site infections after vedolizumab vs anti-TNF therapy: a propensity-matched cohort analysis","volume":"154","author":"Park","year":"2018","journal-title":"Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0016-5085(19)38493-8","article-title":"A pilot study comparing postoperative outcomes after ustekinumab in patients with inflammatory bowel disease","volume":"156","author":"Parrish","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1016\/S0016-5085(18)31630-5","article-title":"Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease","volume":"154","author":"Poylin","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"S1109","DOI":"10.1016\/S0016-5085(13)64135-9","article-title":"Assessment of postoperative complications in patients with IBD. A single academic medical center experience","volume":"144","author":"Quade","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/S0016-5085(19)37179-3","article-title":"Pre-operative biologics significantly reduce post-operative leaks after staged restorative proctocolectomy","volume":"156","author":"Rizvi","year":"2019","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD013256.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/ecco-jcc\/jjv170","article-title":"A multicentre evaluation of risk factors for anastomotic leakage after restorative proctocolectomy with ileal pouch-anal anastomosis for inflammatory bowel disease","volume":"10","author":"Sahami","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000381885","article-title":"Intestinal surgery for Crohn's disease: role of preoperative therapy in postoperative outcome","volume":"32","author":"Scarpa","year":"2015","journal-title":"Digestive Surgery"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jcag\/gwy013","article-title":"Preoperative ustekinumab treatment is not associated with increased postoperative complications in Crohn\u2019s disease: a Canadian multicentre observational cohort study","volume":"1","author":"Shim","year":"2018","journal-title":"Journal of the Canadian Association of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0142|cit142","first-page":"94","article-title":"Impact of preoperative tacrolimus on the postoperative course in patients with ulcerative colitis","volume":"59","author":"Shimada","year":"2016","journal-title":"Diseases of the Colon and Rectum"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1463-1318.2008.01579.x","article-title":"Subtotal colectomy for toxic and fulminant colitis in the era of immunosuppressive therapy","volume":"11","author":"Stewart","year":"2009","journal-title":"Colorectal Disease"},{"issue":"S2","key":"10.1002\/14651858.CD013256.pub2-BIB0144|cit144","first-page":"541","article-title":"Incidence and risk factors of Clostridium difficile infection in patients with ileal pouch-anal anastomosis","volume":"26","author":"Strassle","year":"2017","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0145|cit145","first-page":"33","article-title":"Patients on vedolizumab have a high rate of postoperative complications","volume":"59","author":"Stringfield","year":"2016","journal-title":"Diseases of the Colon and Rectum"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10151-017-1591-2","article-title":"Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn\u2019s disease patients","volume":"21","author":"Valizadeh","year":"2017","journal-title":"Techniques in Coloproctology"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"S633","DOI":"10.1016\/S0016-5085(18)32269-8","article-title":"Rate and risk factors for post-operative complications in Crohn's and colitis patients undergoing non-inflammatory bowel disease surgery","volume":"154","author":"Watson","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0148|cit148","first-page":"S319","article-title":"Anti-TNF exposure is not associated with increased post-operative morbidity or reoperation among Crohn's disease patients","volume":"112","author":"Weber","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0149|cit149","first-page":"55","article-title":"The impact of preoperative immunosuppressive and biologic therapy on complications after surgery for inflammatory bowel disease","volume":"18","author":"Yamamoto","year":"2016","journal-title":"Colorectal Disease"},{"issue":"S1","key":"10.1002\/14651858.CD013256.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1093\/ecco-jcc\/jjx180.749","article-title":"Surgery for severely active ulcerative colitis in the era of new medical treatment: the impacts of medications on surgery avoidance, and short-term and long-term surgical outcomes","volume":"12","author":"Yamamoto","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/DCR.0000000000000099","article-title":"Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease","volume":"57","author":"Ali","year":"2014","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bpg.2018.05.014","article-title":"The impact of biologics in surgical outcomes in ulcerative colitis","volume":"32-33","author":"Argollo","year":"2018","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.crohns.2013.01.014","article-title":"Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis","volume":"7","author":"Billioud","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5114\/aoms.2011.26612","article-title":"A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease","volume":"7","author":"Ehteshami-Afshar","year":"2011","journal-title":"Archives of Medical Science"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/DCR.0b013e3182a48505","article-title":"The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: A systematic review","volume":"56","author":"El-Hussuna","year":"2013","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013256.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/j.gastro.2018.06.046","article-title":"Methotrexate in not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis","volume":"155","author":"Herfarth","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/ibd.22954","article-title":"Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis","volume":"18","author":"Kopylov","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5","key":"10.1002\/14651858.CD013256.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ecco-jcc\/jjy022","article-title":"Systematic review and meta-analysis: preoperative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease","volume":"12","author":"Law","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1524-475x.2000.00547.x","article-title":"Inhibition of tumor necrosis factor-\u0251 attenuates wound breaking strength in rats","volume":"8","author":"Lee","year":"2000","journal-title":"Wound Repair and Regeneration"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","article-title":"Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease","volume":"128","author":"Lichtenstein","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jjw147","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD013256.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/apt.12313","article-title":"Meta-analysis: peri-operative anti-TNF\u03b1 treatment and post-operative complications in patients with inflammatory bowel disease","volume":"37","author":"Narula","year":"2013","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"Journal of Inflammation Research"},{"issue":"32","key":"10.1002\/14651858.CD013256.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.3748\/wjg.v24.i32.3567","article-title":"Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases","volume":"24","author":"Reinglas","year":"2018","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2013-305607","article-title":"Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011","volume":"63","author":"Rungoe","year":"2014","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/1414-431x20143774","article-title":"Classical and recent advances in the treatment of inflammatory bowel diseases","volume":"48","author":"Sales-Campos","year":"2015","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/bjs.5375","article-title":"Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators","volume":"93","author":"Subramanian","year":"2006","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.2008.01942.x","article-title":"Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery","volume":"103","author":"Subramanian","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S11290","article-title":"Current and emerging drugs for the treatment of inflammatory bowel disease","volume":"5","author":"Triantafillidis","year":"2011","journal-title":"Drug Design, Development and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD013256.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4240\/wjgs.v8.i3.274","article-title":"Post-operative abdominal complications in Crohn\u2019s disease in the biological era: Systematic review and meta-analysis","volume":"8","author":"Waterland","year":"2016","journal-title":"World Journal of Gastrointestinal Surgery"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0175|cit175","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"2","key":"10.1002\/14651858.CD013256.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ibd\/izy246","article-title":"Meta-analysis: The influence of preoperative infliximab use on postoperative complications of Crohn's disease","volume":"25","author":"Xu","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"issue":"10","key":"10.1002\/14651858.CD013256.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.12060","article-title":"Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery","volume":"36","author":"Yang","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013256.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijsu.2013.12.015","article-title":"Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2014","journal-title":"International Journal of Surgery"},{"issue":"11","key":"10.1002\/14651858.CD013256.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/ibd\/izy156","article-title":"Systematic review and meta-analysis: Vedolizumab and postoperative complications in inflammatory bowel disease","volume":"24","author":"Yung","year":"2018","journal-title":"Inflammatory Bowel Disease"},{"issue":"12","key":"10.1002\/14651858.CD013256.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3748\/wjg.v20.i12.3146","article-title":"Immunosuppressive therapies for inflammatory bowel disease","volume":"20","author":"Zenlea","year":"2014","journal-title":"World Journal of Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T05:36:03Z","timestamp":1711604163000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013256.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":180,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013256.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,24]]}}}